Correlation Between RenovoRx and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on RenovoRx and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Lipella Pharmaceuticals.
Diversification Opportunities for RenovoRx and Lipella Pharmaceuticals
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between RenovoRx and Lipella is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of RenovoRx i.e., RenovoRx and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between RenovoRx and Lipella Pharmaceuticals
Given the investment horizon of 90 days RenovoRx is expected to generate 4.75 times less return on investment than Lipella Pharmaceuticals. But when comparing it to its historical volatility, RenovoRx is 3.6 times less risky than Lipella Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 575.00 in Lipella Pharmaceuticals Common on August 25, 2024 and sell it today you would lose (312.00) from holding Lipella Pharmaceuticals Common or give up 54.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 97.99% |
| Values | Daily Returns |
RenovoRx vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| RenovoRx |
| Lipella Pharmaceuticals |
RenovoRx and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Lipella Pharmaceuticals
The main advantage of trading using opposite RenovoRx and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |